The state-of-the-art in predictive toxicogenomics

Current Opinion in Drug Discovery and Development

Volumn 9, Issue 1, 2006, Pages 84-91

  Fielden, Mark R ^a   Kolaja, Kyle L ^a  

^a Entelos Inc   (United States)

Author keywords

Biomarker; Classification; Genomics; Microarray; Predictive toxicology; Toxicogenomics

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; TOXIC SUBSTANCE;

ALGORITHM; CLASSIFICATION; DATA BASE; DECISION MAKING; DRUG SAFETY; FINANCIAL MANAGEMENT; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC MARKER; GENOMICS; HUMAN; KNOWLEDGE; MICROARRAY ANALYSIS; NORTHERN BLOTTING; PREDICTION; PREDICTIVE TOXICOGENOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TOXICITY; VALIDATION PROCESS;

ALGORITHMS; ANIMALS; BIOLOGICAL MARKERS; DATABASES; DATABASES AS TOPIC; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; TOXICITY TESTS; TOXICOGENETICS;

EID: 30744469621     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Thomas RS, Rank DR, Penn SG, Zastrow GM, Hayes KR, Pande K, Glover E, Silander T, Craven MW, Reddy JK, Jovanovich SB et al: Identification of toxicologically predictive gene sets using cDNA microarrays. Mol Pharmacol (2001) 60(6):1189-1194. Provides one of the first published examples of the application of a classification algorithm for deriving a class predictor of toxicological mechanism using a large microarray dataset.
2. Hamadeh HK, Bushel PR, Jayadev S, DiSorbo O, Bennett L, Li L, Tennant R, Stoll R, Barrett JC, Paules RS, Blanchard K et al: Prediction of compound signature using high density gene expression profiling. Toxicol Sci (2002) 67(2):232-240.
3. Waters M, Boorman G, Bushel P, Cunningham M, Irwin R, Merrick A, Olden K, Paules R, Selkirk J, Stasiewicz S, Weis B et al: Systems toxicology and the chemical effects in biological systems (CEBS) knowledge base. EHP Toxicogenomics (2003) 111(1T):15-28.
4. Pennie W, Pettit SD, Lord PG: Toxicogenomics in risk assessment: An overview of an HESI collaborative research program. Environ Health Perspect (2004) 112(4):417-419.
5. Somorjai RL, Dolenko B, Baumgartner R: Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: Curses, caveats, cautions. Bionformatics (2003) 19(12):1484-1491. Provides an evaluation of the effect of dataset sparsity and the curve of dimensionality in microarray data, and casting doubt on the relevance of optimal classifiers.
6. Simon R: Using DNA microarrays for diagnostic and prognostic prediction. Expert Rev Mol Diagnostics (2003) 3(5):587-595.
7. Natsoulis G, El Ghaoui L, Lanckriet GR, Tolley AM, Leroy F, Dunlea S, Eynon BP, Pearson CI, Tugendreich S, Jamagin K: Classification of a large microarray dataset: Algorithm comparison and analysis of drug signatures. Genome Res (2005) 15(5):724-736. Provides a comparison of the classification performance and interpretability of various linear and non-linear classifiers for pharmacological and toxicological classification of a large microarray dataset.
8. van Delft JH, van Agen E, van Breda SG, Herwijnen MH, Staal YC, Kleinjans JC: Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutat Res (2005) 575(1-2):17-33.
9. van Delft JH, van Agen E, van Breda SG, Herwijnen MH, Staal YC, Kleinjans JC: Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis(2004) 25(7):1265-1276.
10. Mattes WB, Pettit SD, Sansone SA, Bushel PR, Waters MD: Database development in toxicogenomics: Issues and efforts. Environ Health Perspect (2004) 112(4):495-505. Provides a review of the issues and efforts involved in constructing a public toxicogenomic database and data standards.
11. Boorman GA, Blackshear PE, Parker JS, Lobenhofer EK, Malarkey DE, Valiant MK, Gerken DK, Irwin RD: Hepatic gene expression changes throughout the day in the Fischer rat: Implications for toxicogenomic experiments. Toxicol Sci (2005) 86(1):185-193.
12. Irwin RD, Parker JS, Lobenhofer EK, Burka LT, Blackshear PE, Vallant MK, Lebetkin EH, Gerken DF, Boorman GA: Transcriptional profiling of the left and median liver lobes of male f344/n rats following exposure to acetaminophen. Toxicol Pathol (2005) 33(1):111-117.
13. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, Gaasterland T et al: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet (2001) 29(4):365-371.
14. Spellman PT, Miller M, Stewart J, Troup C, Sarkans U, Chervitz S, Bernhart D, Sherlock G, Ball C, Lepage M, Swiatek M et al: Design and Implementation of microarray gene expression markup language (MAGE-ML). Genome Biol (2002) 3(9):RESEARCH0046.
15. Steiner G, Suter L, Boess F, Gasser R, de Vera MC, Albertini S, Ruepp S: Discriminating different classes of toxicants by transcript profiling. Environ Health Perspect (2004) 112(12):1236-1248. Describes the application of a supervised classification algorithm on a large volume of microarray data for the identification, characterization and validation of signatures to predict hepatotoxicity.
16. McMillian M, Nie AY, Parker JB, Leone A, Kemmerer M, Bryant S, Herlich J, Yieh L, Bittner A, Liu X, Wan J et al: Inverse gene expression patterns for macrophage activating hepatotoxicants and peroxisome proliferators in rat liver. Biochem Pharmacol (2004) 67(11):2141-2165.
17. Kier LD, Neft R, Tang L, Suizu R, Cook T, Onsurez K, Tiegler K, Sakai Y, Ortiz M, Nolan T, Sankar U et al: Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro. Mutat Res (2004) 649(1-2):101-113.
18. Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, Bostian KA, Brady L, Browne LJ, Calvin JT, Day GJ, Breckenridge N et a: Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol (2005) 119(3):219-244. Describes the methods used to construct, standardize and control quality in one of the largest chemogenomic databases for drug discovery and development applications.
19. Fielden MR, Pearson C, Brennan R, Kolaja KL: Preclinical drug safety analysis by chemogenomic profiling in the liver. Am J Pharmacogenomics (2005) 5(3):161-171.
20. Fielden MR, Eynon BP, Natsoulis G, Jamagin K, Banas D, Kolaja KL: A gene expression signature that predicts the future onset of drug-induced renal tubular toxicity. Toxicol Pathol (2005) 33(6):675-683. Provides the first published example demonstrating the derivation and validation of a signature that predicts histopathological renal tubular injury weeks before it is detected histologically.
21. El Ghaoui L, Lanckriet GRG, Natsoulis G: Robust classifiers with interval data: Computer Science Division (EECS), University of California, Berkeley, CA, USA (2003). http://www.eecs.berkeley.edu/Pubs/TechRpts/2003/CSD-03-1279.pdf
22. Thukral SK, Nordone PJ, Hu R, Sullivan L, Galambos E, Fitzpatrick VD, Healy L, Bass MB, Cosenza ME, Afshari CA: Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol Pathol (2005) 33(3):343-355.
23. Brown MP, Grundy WN, Lin D, Cristianini N, Sugnet CW, Furey TS, Ares M Jr, Haussler D: Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA (2000) 97(1):262-267.
24. Amin RP, Vickers AE, Sistare F, Thompson KL, Roman RJ, Lawton M, Kramer J, Hamadeh HK, Collins J, Grissom S, Bennett L et al: Identification of putative gene-based markers of renal toxicity. Environ Health Perspect (2004) 112(4):465-479.
25. Ruepp S, Boess F, Suter L, de Vera MC, Steiner G, Steele T, Weiser T, Albertini S: Assessment of hepatotoxic liabilities by transcript profiling. Toxicol Appl Pharmacol(2005) 207(2 Suppl):161-170.
26. Boess F, Kamber M, Romer S, Gasser R, Muller D, Albertini S, Suter L: Gene expression in two hepatic cell lines, cultured primary hepatocytes and liver slices compared to the in vivo liver gene expression in rats: Possible implications for toxicogenomics use of in vitro systems. Toxicol Sci (2003) 73(2):386-402.
27. Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG: Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett (2001) 120(1-3):359-368.
28. Sawada H, Takami K, Asahi S: A toxicogenomic approach to drug-induced phospholipidosis: Analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci (2005) 83(2):282-292. Describes the identification of 12 genes in HepG2 cells that diagnose the ability of a compound to induce phospholipidosis, and discusses validation and application in an in vitro screening assay.
29. Waters MD, Fostel JM: Toxicogenomics and systems toxicology: Aims and prospects. Nat Rev Genet (2004) 5(12):936-948.